Target- |
MechanismαIIbβ3 inhibitors |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with αIIbβ3
100 Translational Medicine associated with αIIbβ3
0 Patents (Medical) associated with αIIbβ3